📰 Eng Eong News
Page 2 - Eng Eong News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eng Eong. Real-time updates on events, politics, business and more.
March 19, 2023
Singapore will be the first country in Asia to get Pfizer’s new pneumococcal vaccine, which has a broader range of protection and could replace the two that are now in use here.
January 19, 2023
Health News - It has been about three years since Sars-CoV-2, the virus that causes Covid-19, made its presence felt in the world. Bivalent vaccines, which have been reformulated to target new variants, are now readily available here. Here are some of the questions that you may have... Read more at www.tnp.sg
January 16, 2023
SINGAPORE - People in Singapore who have received their mRNA booster shots are well protected against severe Covid-19, and this applies even when it involves new virus variants like the Kraken, said Professor Ooi Eng Eong, an expert in emerging infectious diseases at Duke-NUS Medical School. This is what is important now that Covid-19 is endemic – that people do...
January 16, 2023
Singapore News - People in Singapore who have received their mRNA booster shots are well protected against severe Covid-19, and this applies even when it involves
November 14, 2022
The American study had suggested that those infected with Covid-19 a second time are at higher risk of organ failure and death. Read more at straitstimes.com.
November 14, 2022
Singapore News - An American study suggesting that people who are infected with Covid-19 a second time are at higher risk of organ failure and death is questionable, with inherent limitations and overstated conclusions, say local experts. The retrospective study by the Washington University... Read more at www.tnp.sg
October 17, 2022
QDENGA TAK-003 is a tetravalent dengue vaccine
October 16, 2022
Japan: Takeda has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takedas dengue vaccine candidate,...
October 14, 2022
TAK-003 Recommended for the Prevention of Dengue Disease Caused by Any Dengue Virus Serotype in Individuals Four Years of Age and Older in the EU and in Dengue-Endemic Countries Participating in
October 14, 2022
14.10.2022 - Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takeda’s dengue vaccine candidate, TAK-003, for the prevention of dengue ...